Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Katja C. Zimmermann

Katja C. Zimmermann publishes mostly in Molecular Biology, Law and Cardiology and Cardiovascular Medicine, on topics such as Biochemical and Molecular Research, European and International Contract Law and Cell death mechanisms and regulation.

ORCID 0000-0002-3356-8757 OpenAlex
World rank
#591,835
of 7,710,434 ranked researchers
Rank in Germany
#29,104
of 364,343
Works
57
Citations
8.1k
Citations per work
141.8
h-index
21
i10-index 24Top 30% in Molecular Biology
Katja C. Zimmermann

What does Katja C. Zimmermann research?

Katja C. Zimmermann's work is mostly in Biochemistry, Genetics and Molecular Biology (23%), Medicine (8%), Social Sciences (7%).

Everything else: 33 works · 57.8% of their workLife Sciences: 15 works · 26.8% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 23.0% of their workMolecular Biology: 10 works · 17.9% of their workCancer Research: 3 works · 5.1% of their workImmunology and Microbiology: 2 works · 3.8% of their workImmunology: 2 works · 3.8% of their workHealth Sciences: 5 works · 8.3% of their workMedicine: 5 works · 8.3% of their workCardiology and Cardiovascular Medicine: 3 works · 5.1% of their workPharmacology: 2 works · 3.2% of their workSocial Sciences: 4 works · 7.1% of their workSocial Sciences: 4 works · 7.1% of their workLaw: 4 works · 7.1% of their workTHEIR WORKKatja C.Zimmermann57works
Life Sciences27%Health Sciences8%Social Sciences7%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3357.8%
    1. Biochemistry, Genetics and Molecular Biology1323.0%
    2. Immunology and Microbiology23.8%
    1. Medicine58.3%
    1. Social Sciences47.1%
  1. 1Molecular Biology18% of their works
  2. 2Law7% of their works
  3. 3Cardiology and Cardiovascular Medicine5% of their works
  4. 4Cancer Research5% of their works
  5. 5Immunology4% of their works
  6. 6Pharmacology3% of their works

Research topics

Which keywords describe Katja C. Zimmermann's research?

The keywords of their largest research topics: Legal Transplants, Enzyme Regulation, Nucleotide Metabolism, Consumer Protection, European Private Law, Antiretroviral Therapy, Apoptosis and Cell Death.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Legal Transplants102 topics
  2. Enzyme Regulation81 topic
  3. Nucleotide Metabolism81 topic
  4. Consumer Protection61 topic
  5. European Private Law61 topic
  6. Antiretroviral Therapy51 topic
  7. Apoptosis51 topic
  8. Cell Death51 topic
  9. Cyclooxygenase-2 Inhibitors51 topic
  10. HIV Infection51 topic
  11. Inflammation51 topic
  12. CD4741 topic
  13. European Company Law41 topic
  14. HIF-141 topic
  15. Regulatory Competition41 topic
  16. Warburg Effect41 topic
  17. apoptotic cells41 topic

Where does Katja C. Zimmermann work?

Katja C. Zimmermann's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Katja C. Zimmermann have?

OpenAlex counts 57 works and 8,080 citations for Katja C. Zimmermann, an h-index of 21, ranking #591,835 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Katja C. Zimmermann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.